PT1370245E - Metodo para preparar microparticulas contendo metoprolol - Google Patents

Metodo para preparar microparticulas contendo metoprolol

Info

Publication number
PT1370245E
PT1370245E PT02701873T PT02701873T PT1370245E PT 1370245 E PT1370245 E PT 1370245E PT 02701873 T PT02701873 T PT 02701873T PT 02701873 T PT02701873 T PT 02701873T PT 1370245 E PT1370245 E PT 1370245E
Authority
PT
Portugal
Prior art keywords
microparticles containing
preparing microparticles
metoprolol
containing metoprolol
microparticles
Prior art date
Application number
PT02701873T
Other languages
English (en)
Portuguese (pt)
Inventor
Djurle Alf
Hansson Mikael
Soederbom Malin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PT1370245E publication Critical patent/PT1370245E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
PT02701873T 2001-03-09 2002-03-06 Metodo para preparar microparticulas contendo metoprolol PT1370245E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100824A SE0100824D0 (sv) 2001-03-09 2001-03-09 Method III to obtain microparticles

Publications (1)

Publication Number Publication Date
PT1370245E true PT1370245E (pt) 2005-08-31

Family

ID=20283295

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02701873T PT1370245E (pt) 2001-03-09 2002-03-06 Metodo para preparar microparticulas contendo metoprolol

Country Status (24)

Country Link
US (1) US20040116392A1 (OSRAM)
EP (1) EP1370245B1 (OSRAM)
JP (1) JP2004522798A (OSRAM)
KR (1) KR20030081507A (OSRAM)
CN (1) CN1236761C (OSRAM)
AT (1) ATE295153T1 (OSRAM)
AU (1) AU2002235102B2 (OSRAM)
BR (1) BR0207919A (OSRAM)
CA (1) CA2440167A1 (OSRAM)
DE (1) DE60204125T2 (OSRAM)
ES (1) ES2240691T3 (OSRAM)
HU (1) HUP0303450A2 (OSRAM)
IL (1) IL157777A0 (OSRAM)
IS (1) IS6937A (OSRAM)
MX (1) MXPA03008088A (OSRAM)
NO (1) NO20033967L (OSRAM)
NZ (1) NZ528168A (OSRAM)
PL (1) PL363972A1 (OSRAM)
PT (1) PT1370245E (OSRAM)
RU (1) RU2292878C2 (OSRAM)
SE (1) SE0100824D0 (OSRAM)
UA (1) UA75909C2 (OSRAM)
WO (1) WO2002072074A1 (OSRAM)
ZA (1) ZA200306880B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
US8006685B2 (en) * 2002-07-05 2011-08-30 Turbochef Technologies, Inc. Re-circulating oven with gas clean-up
PL1915137T3 (pl) 2005-08-10 2014-03-31 Add Advanced Drug Delivery Tech Ltd Preparat doustny o kontrolowanym uwalnianiu
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
BRPI0714586A2 (pt) * 2006-07-28 2013-05-07 Farmaprojects S A formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço
US20110014295A1 (en) * 2007-02-23 2011-01-20 Glatt Air Techniques, Inc. Method of determining the weight of the coating to be applied to form a controlled release dosage form
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
CN101820863A (zh) * 2007-10-10 2010-09-01 马林克罗特贝克公司 直接可压制的高功能性颗粒状微晶纤维素基赋形剂、其制备方法和用途
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CN102641257A (zh) * 2012-03-31 2012-08-22 内蒙古医学院 阿替洛尔缓释微囊及其制备方法
RU2585023C1 (ru) * 2014-12-18 2016-05-27 Общество с ограниченной ответственностью "Нанолек" Способ гранулирования
CN104739805B (zh) * 2015-04-09 2017-12-19 邸蓉 制备琥珀酸美托洛尔缓释微丸的复相乳液法
ES3040411T3 (en) 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
CN115252913A (zh) * 2022-08-02 2022-11-01 赛诺神畅医疗科技有限公司 一种血管给药涂层及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US653014A (en) * 1899-10-06 1900-07-03 Ashley & Bailey Company Process of silkifying cotton.
SE354851B (OSRAM) * 1970-02-18 1973-03-26 Haessle Ab
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
EP0163836B1 (de) * 1984-04-07 1988-10-12 Bayer Ag Verfahren und Vorrichtung zur Herstellung von Granulaten
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
DE3909455A1 (de) * 1989-03-22 1990-09-27 Hoechst Ag Verfahren zur herstellung von wasserdispergierbaren granulaten
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
AU6824996A (en) * 1995-08-17 1997-03-12 Dyer, Alison Margaret Controlled release products
DE19613395A1 (de) * 1996-04-03 1997-10-09 Basf Ag Granulate hygroskopischer, wasserlöslicher Produkte
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19733094A1 (de) * 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität
DE59813833D1 (de) * 1997-10-15 2007-01-11 Merck Patent Gmbh Herstellung eines direkt verpressbaren tablettierhilfsstoffes
EP0987020A1 (en) * 1998-09-04 2000-03-22 Pharma Pass LLC Metoprolol composition and processes for manufacturing the same
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
NZ525231A (en) * 2000-09-20 2004-08-27 Skyepharma Canada Inc Phospholipid stabilised feno-fibrate microparticles for pharmaceutical use
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles

Also Published As

Publication number Publication date
HUP0303450A2 (hu) 2004-01-28
ZA200306880B (en) 2004-12-03
RU2003127739A (ru) 2005-03-10
ES2240691T3 (es) 2005-10-16
NO20033967L (no) 2003-10-28
CN1507345A (zh) 2004-06-23
ATE295153T1 (de) 2005-05-15
NZ528168A (en) 2005-01-28
KR20030081507A (ko) 2003-10-17
UA75909C2 (en) 2006-06-15
SE0100824D0 (sv) 2001-03-09
HK1059737A1 (en) 2004-07-16
DE60204125D1 (de) 2005-06-16
NO20033967D0 (no) 2003-09-08
EP1370245B1 (en) 2005-05-11
CA2440167A1 (en) 2002-09-19
US20040116392A1 (en) 2004-06-17
DE60204125T2 (de) 2006-01-19
WO2002072074A1 (en) 2002-09-19
PL363972A1 (en) 2004-11-29
MXPA03008088A (es) 2003-12-12
JP2004522798A (ja) 2004-07-29
IS6937A (is) 2003-09-03
AU2002235102B2 (en) 2006-08-31
EP1370245A1 (en) 2003-12-17
CN1236761C (zh) 2006-01-18
IL157777A0 (en) 2004-03-28
BR0207919A (pt) 2004-04-27
RU2292878C2 (ru) 2007-02-10

Similar Documents

Publication Publication Date Title
NO20033967D0 (no) Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol
ATE380109T1 (de) Systeme, verfahren und vorrichtungen zur herstellung von dosierformen
ATE267657T1 (de) Verfahren zur herstellung von freiform-produkten
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
IL165696A0 (en) Substituted 1,3-diphenykprop-2-en-1-one derivatives and preparation and uses thereof
HK1042091A1 (zh) 金剛烷衍生物
SE9901875D0 (sv) Novel compounds
MY113488A (en) Compounds with growth hormone releasing properties
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
MXPA05012678A (es) Forma cristalina del agonista del receptor adrenergico beta2.
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
SE9904505D0 (sv) Novel compounds
SE0300480D0 (sv) Novel compounds
HUP0001945A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical copositions containing them
ZA200306614B (en) Method to obtain microparticles containing a H +, K + -ATP-ase inhibitor.
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
HUP0003641A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
IL165086A0 (en) Cyanoguanidine prodrugs
SE0202693D0 (sv) Compounds
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
UY26435A1 (es) Compuestos bis-básicos como inhibidores de triptasa, procedimiento para su preparación y su utilización como medicamentos.
IL176145A0 (en) Pyrazolopyrimidines
HUP0103686A2 (en) Use of rolipram, ariflo or diazepino-indole, triazolo-quinazoline derivatives for the preparation of pharmaceutical compositions preventing or treating diseases associated with an excess in il-12 production
UA67597A (en) Method for treating prostate cancer